Evidence USA | Pharma Pricing & Market Access USA 2017 

Philadelphia, PA

10/10 - 10/11



Dr. Matt Yuen to Attend the Evidence USA | Pharma Pricing & Market Access USA 2017 Conference


Decision Driver Analytics (DDA), a premier provider of health economics, epidemiology, and real-world evidence strategies for drug and medical device developers, will provide expertise in observational research at the Evidence USA | Pharma Pricing & Market Access USA 2017 conference.  “Attending America's biggest access, pricing, and reimbursement event gives us the opportunity to provide valuable insight to developers on how to generate real world evidence via observational studies to impact market access,” said Dr. Matt Yuen, Director of Health Policy and Research. “The DDA team will be there to demonstrate how our services can effectively communicate the value of products to investors, health care providers, payors and patients.”


“Payors often interpret data from studies differently,” Dr. Yuen said. “We’ll discuss what payors are looking for, how to collect the data you need and how to best leverage data.”


Decision Driver Analytics was formed in 2006 to provide accessible health economics and practical evidence generation strategies and tactics to impact market access for innovative products. Our broad therapeutic experience with pharmaceutical, biotechnology and medical device clients has led to the creation of numerous health economic models and market development programs. DDA staff frequently present at industry conferences and have published numerous peer-reviewed articles covering a variety of health economics and epidemiological topics.


Attendees can schedule an appointment with Dr. Yuen at myuen@decision-driver.com.